Pharmaceutical preparations for the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of neuropathic pain, cancer pain, multiple sclerosis, spinal cord injury, bladder dysfunction, peripheral neuropathy, spasticity, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, and metabolic disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for therapeutic purposes in the treatment of pain, disease, illness, and injury; pharmaceutical preparations for the treatment of mental illness; dietary supplements; all of the foregoing containing CBD solely derived from hemp with a delta-9 tetrahydrocannabinol (THC) concentration of not more than 0.3 percent on a dry weight basis

'-9':84 '0.3':92 'basi':98 'bladder':27 'cancer':20,32 'cbd':76 'concentr':87 'contain':75 'cord':25 'delta':83 'deriv':78 'dietari':69 'diseas':8,37,57 'disord':40 'dri':96 'dysfunct':28 'forego':74 'hemp':80 'ill':9,35,58,68 'injuri':11,26,60 'mental':67 'metabol':39 'multipl':22 'neurodegen':36 'neuropath':18 'neuropathi':30 'oncolog':46 'pain':7,19,21,56 'percent':93 'peripher':29 'pharmaceut':1,12,41,47,61 'prepar':2,13,42,48,62 'psychiatr':34 'purpos':51 'sclerosi':23 'sole':77 'spastic':31 'spinal':24 'supplement':70 'symptom':33 'tetrahydrocannabinol':85 'thc':86 'therapeut':50 'treatment':5,16,54,65 'use':44 'weight':97

CBD SCIENCE

Owner

Goods & Services